Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Grimshaw, US

Kirk T. Grimshaw, Marne, MI US

Patent application numberDescriptionPublished
20110096138COMMUNICATION SYSTEM - A communication system that may be integrated or otherwise combined with a piece of furniture, such as a conference table, desk or credenza. The communication system may provide a combination of audio, video, telephony, presentation and/or other conferencing functions and may include a number of separate user modules, a control module, a display module and a network connection. According to an exemplary embodiment, each of the separate user modules is a compact device that is integrated into the piece of furniture and includes a button that, when activated, allows a user to take control of certain aspects of the communication system. For example, a user may take over the display module or the information that is sent via the network connection by activating their user module.04-28-2011

Matthew T. Grimshaw, Seattle, WA US

Patent application numberDescriptionPublished
20110030380HIGH STIFFNESS SHAPE MEMORY ALLOY ACTUATED AEROSTRUCTURE - A shape memory alloy (SMA) actuated aerostructure operable to dynamically change shape according to flight conditions is disclosed. Deformable structures are actuated by SMA actuators that are coupled to face sheets of the deformable structures. Actuating the SMA actuators produces complex shape changes of the deformable structures by activating shape changes of the SMA actuators. The SMA actuators are actuated via an active or passive temperature change based on operating conditions. The SMA actuated aerostructure can be used for morphable nozzles such as a variable area fan nozzle and/or a variable geometry chevron of a jet engine to reduce engine noise during takeoff without degrading fuel burn during cruise.02-10-2011

Michael Grimshaw, Saint Louis, MO US

Patent application numberDescriptionPublished
20080299189CONTROLLED RELEASE DOPAMINE AGONIST COMPOSITIONS - The present invention relates to a multiphase release oral pharmaceutical formulation having a dopamine agonist as an active ingredient. The multiphase composition comprises at least two different release components. The invention relates to controlled release pharmaceutical compositions of pramipexole or a pharmaceutically acceptable salt thereof for once-daily administration.12-04-2008

Michael Norman Grimshaw, Saint Louis, MO US

Patent application numberDescriptionPublished
20090035370DOSAGE FORM AND METHOD OF USE - A method for treating a medical condition for which quetiapine is indicated in a subject comprises comprising orally administering to the subject quetiapine or a pharmaceutically acceptable salt thereof in a daily dosage amount effective to treat said condition; wherein the quetiapine or salt thereof is administered in one to a plurality of dosage forms collectively comprising (a) a major quetiapine component in immediate-release form in a sedative effective amount, administered not earlier than about 3 hours prior to the start of a sleep period; and (b) either (i) a minor quetiapine component in extended-release, delayed extended-release or delayed pulsed-release form, wherein time of administration and release properties of the minor component provide substantial onset of release of quetiapine therefrom not earlier than about 6 hours after the start of the sleep period, or (ii) a plurality of minor quetiapine components in immediate-release form, administered sequentially during a waking period following the sleep period but not earlier than about 6 hours after the start of the sleep period; said minor component or components collectively being administered in an anxiolytic effective amount insufficient to cause an unacceptable degree of sedation. A dosage form suitable for use in such a method is also provided.02-05-2009

Michael Peter Grimshaw, Vancouver, WA US

Patent application numberDescriptionPublished
20090168826Semiconductor lasers utilizing optimized n-side and p-side junctions - A semiconductor laser and a method of forming the same are provided. The n-side and p-side junctions are independently optimized to improve carrier flow. The material for the n-side cladding layer is selected to yield a small conduction to valance band gap offset ratio while the material for the p-side cladding layer is selected to yield a large conduction to valance band gap offset ratio.07-02-2009

Patent applications by Michael Peter Grimshaw, Vancouver, WA US

Paul Grimshaw, Acton, MA US

Patent application numberDescriptionPublished
20100010360Atrial Fibrillation Detection - Atrial fibrillation is detected in an electrical signal representative of a beating heart by measuring atrial activity over a time window of three or more beats, measuring beat interval variation over the time window and combining the measures of atrial activity and beat interval variation to produce an indication of an atrial fibrillation condition in the electrical signal.01-14-2010

Patent applications by Paul Grimshaw, Acton, MA US

Scott Grimshaw, Marcellus, NY US

Patent application numberDescriptionPublished
20090071229NOx SENSOR AND METHOD FOR DETECTING NOx03-19-2009

Scott F. Grimshaw, Marcellus, NY US

Patent application numberDescriptionPublished
20100238035DETECTION DEVICE AND METHOD FOR DETECTING ANALYTE - There is provided a detection device that comprises a light source, a light sensor and an at least partially light-transmitting element that supports growth of at least one analyte selected from among fungi and bacteria. The light source, the at least partially light-transmitting element and the light sensor are positioned relative to one another and oriented relative to one another such that when the light source is illuminated, at least some of the light emitted from the light source passes through the at least partially light-transmitting element and is received by the light sensor. There is also provided a method of detecting an analyte, comprising illuminating a light source to emit light, and detecting an intensity of light that passes through an at least partially light-transmitting device that comprises an at least partially light-transmitting element that supports growth of at least one analyte selected from among fungi and bacteria.09-23-2010

Patent applications by Scott F. Grimshaw, Marcellus, NY US

Scott F. Grimshaw, Greenville, SC US

Patent application numberDescriptionPublished
20110157863ENHANCED VISIBILITY CLOTHING AND SAFETY DEVICES, AND METHODS OF ILLUMINATING CLOTHING - A safety device comprising an article of clothing, first and second chambers in which first and second chemiluminescent compositions (which, if mixed, would produce electromagnetic radiation) are positioned, respectively. Also, a safety device comprising an article of clothing, tubing affixed to the clothing, the tubing defining a first chamber, first and second chemiluminescent compositions and a pump which is activatable to move at least the first chemiluminescent composition within the first chamber. Also, a method of illuminating an article of clothing, comprising mixing first and second chemiluminescent compositions to form a chemiluminescent mixture, and pumping the chemiluminescent mixture within at least a first chamber. Also, a method of illuminating an article of clothing, comprising mixing first and second chemiluminescent compositions in a first chamber, the first chamber being affixed to an article of clothing.06-30-2011

Stephen B. Grimshaw, Orlando, FL US

Patent application numberDescriptionPublished
20090109063Airborne vehicle emulation system and method - An apparatus includes a first interface configured to communicate via a first protocol, and a first holding device configured to hold an airborne vehicle. The first holding device includes a second interface configured to communicate with the first interface via the first protocol, and to communicate with the airborne vehicle via a second protocol. The apparatus includes an emulator configured to convert at least one of a communication of the first protocol into a communication of the second protocol, and a communication of the second protocol into a communication of the first protocol.04-30-2009

Suzanne Grimshaw, Poway, CA US

Patent application numberDescriptionPublished
20090324551TLR AGONISTS - The present invention provides for TLR agonist conjugates (compounds) and compositions, as well as methods of using them. The compounds of the invention are broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal, preferably a human and can help direct the pharmacophore to the receptor within the endosomes of target cells and enhance the signal transduction induced by the pharmacophore.12-31-2009
20110098294PURINE ANALOGS - The present invention provides a new patentable class of purine analog compounds, as well as compositions and methods of using them, for example, to prevent or treat various diseases and disorders in human and non-human animals.04-28-2011